在医学中以不同方式向onabotulinumtoxinA的临床条件
Dilara Onan1, Fatemeh Farham2, Paolo Martelletti3
1Department of Physiotherapy and Rehabilitation, Faculty of Heath Sciences, Yozgat Bozok University, Yozgat 66000, Turkey.
Toxins
|July 26, 2024
概括
胺毒素A (BT-A) 除了肌肉放松之外,还提供各种治疗益处. 这种毒素针对疼痛,脱发甚至癌症治疗的各种应用途径,扩大了其医疗效用.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 皮肤病学 皮肤病学
背景情况:
- 已知onabotulinumtoxinA (BT-A) 通过乙胆阻断导致肌肉麻.
- 新兴研究表明,BT-A具有独立于神经肌肉结点目标的治疗应用.
研究的目的:
- 在各种医疗应用中探索OnabotulinumtoxinA (BT-A) 的各种途径目标.
- 审查BT-A在已建立的机制之外不断扩大的治疗用途.
主要方法:
- 对研究OnabotulinumtoxinA (BT-A) 应用的研究文献综述.
- 对BT-A在不同疾病中的作用机制的分析.
主要成果:
- 通过影响乙胆,BT-A用于化品,泌尿和神经疾病.
- 此外,BT-A还向谷氨酸,CGRP和物质P等疼痛调解剂,以缓解疼痛.
- 新的应用包括脱发治疗 (准TGF-β1) 和潜在的抗癌作用 (诱导亡).
结论:
- 毒素A (BT-A) 通过多种生物途径表现出广泛的治疗效果.
- 重复的BT-A应用在各种医疗领域增强了长期益处.
- BT-A的多功能性支持其不断扩大的使用和不断发现新的治疗潜力.
关键词:
这是CGRP的CGRP.它是一种玻丁毒素A.慢性偏头痛 慢性偏头痛 慢性偏头痛过度出汗 过度出汗 过度出汗脱发 脱发 脱发 脱发 脱发 脱发 脱发 脱发 脱发性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性等.三分生神经疼痛 三分生神经疼痛纹 纹 纹更多相关视频
相关概念视频
Skeletal Muscle Relaxants: Therapeutic Uses
477
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
477
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
664
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
664
Cholinergic Antagonists: Therapeutic Uses
737
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
737
Direct-Acting Cholinergic Agonists: Therapeutic Uses
712
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
712
Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
654
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
654


